Incidence and Risk Factors of Early Onset Colorectal Cancer
January 14, 2022 updated by: Ivana Mikoviny Kajzrlikova, MD, PhD, Hospital Frydek-Mistek
Early onset colorectal cancer (cancer in person younger than 50 years) has increasing incidence last years.
The aim of our study was to assess the real-life incidence of early onset colorectal cancer, advanced neoplasias (colorectal cancer and/or advanced adenoma) and all neoplastic lesions in total in a single non-university endoscopic center.
Study Overview
Detailed Description
The investigators retrospectively assessed the incidence of all neoplastic lesions, advanced neoplasias and colorectal cancer in population under 50 years of age compared to population 50 years and older.
The investigators collected the data from all colonoscopic examinations performed in non-university hospital Frydek-Mistek from January 2012 to the end of June 2021.
Study Type
Observational
Enrollment (Actual)
18257
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 97 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
all patients who were indicated for colonoscopic examination (all indications) in period january 2012 to the end of june 2021
Description
Inclusion Criteria: all patient who underwent colonoscopic examination clear indication for colonoscopy
Exclusion Criteria: not able to underwent colonoscopy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
50 years and over
patients who underwent colonoscopic examination aged 50 years and over
|
|
|
under 50 years
patients who underwent colonoscopic examination aged under 50 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of early onset colorectal neoplasias, risk factors
Time Frame: 10 years
|
the real-life incidence of early onset colorectal cancer, advanced neoplasias (colorectal cancer and/or advanced adenoma) and all neoplastic lesions in total in a single non-university endoscopic center, the risk of sex and family history of colorectal cancer
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ivana Mikoviny Kajzrlikova, Hospital Frydek-Mistek
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
December 1, 2021
Study Registration Dates
First Submitted
December 22, 2021
First Submitted That Met QC Criteria
December 22, 2021
First Posted (Actual)
January 11, 2022
Study Record Updates
Last Update Posted (Actual)
January 31, 2022
Last Update Submitted That Met QC Criteria
January 14, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Early onset colorectal cancer
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.